Innovation follows laboratory work on its way to application: what stage a technology has reached, which problems remain unsolved, and how many years typically separate a demonstration from something purchasable. Hype cycles are named as such. For investors, researchers and readers tracking developments that are genuinely near-term.
Innovation follows laboratory work on its way to application: what stage a technology has reached, which problems remain unsolved, and how many years typically separate a demonstration from something purchasable. Hype cycles are named as such. For investors, researchers and readers tracking developments that are genuinely near-term.
A Charlotte training center shows why device innovation fails in the operating room when nobody practices the whole setup.
A new thing is not an innovation until someone uses it and value moves. The definition is stricter than the marketing suggests.
Why some of the world's most useful devices come from tight budgets, and what the word 'frugal' actually carries into engineering.
The 3rd France-Atlanta Science & Innovation Summit is small news with a readable signal: governments now court researchers the way brands court customers.
A 2026 study in Nature Medicine tracked a man with ALS using a brain-computer interface independently at home for nearly two years — a long-term, single-participant test of whether such systems can work outside the lab, not yet a device anyone else can buy.
Direct air capture fights thermodynamics before it fights economics: carbon dioxide is vanishingly dilute in air, and every ton collected must be paid for in energy, materials, and machines.
After decades of near-silence, new antibiotic classes are reaching patients — not by overpowering resistance, but by finding targets the older drugs never touched.
By reading gene activity one cell at a time, researchers discovered that 'identical' cells differ in ways that average measurements had smoothed away — reshaping how disease is classified.
Implants that translate brain signals into action pass through years of bench work, animal studies, and small human trials under close regulatory watch — the record so far is promising but short.